ClinicalTrials.govpublic full text
Study of Oral Rucaparib With Other Anticancer Agents in Metastatic Castration Resistant Prostate Cancer Patients (RAMP)
metastatic castration resistant prostate cancer, crpc, parp inhibitor, ramp, homologous recombination, dna repair, dna defect, dna anomaly, mcrpc, enzalutamide, abiraterone, zytiga
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 879524
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.